---
title: "Kalaris Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d
json: https://whiteintel.dev/api/public/dossier/de4c956a-976e-5209-89f2-2f72662ee99d
identifier: sec:0001754068
jurisdiction: US
risk: High
source: WhiteIntel corporate-ownership graph
---

# Kalaris Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001754068`  
**Risk level:** High  
**Canonical dossier:** https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/de4c956a-976e-5209-89f2-2f72662ee99d  

## Ownership & control

### Owners / controllers

- **AKKARAJU SRINIVAS** (10% owner) — https://whiteintel.dev/entity/ec9ac26b-07ce-5595-b013-3e7386eb27ef
- **Samsara BioCapital GP, LLC** (10% owner) — https://whiteintel.dev/entity/f27fb560-ac80-5f57-aada-2abf63da4070
- **Samsara BioCapital, L.P.** (10% owner) — https://whiteintel.dev/entity/288d366d-faca-54e6-a55f-2d1f307cc7f2
- **AKKARAJU SRINIVAS** (10% owner) — https://whiteintel.dev/entity/ec9ac26b-07ce-5595-b013-3e7386eb27ef
- **AKKARAJU SRINIVAS** (10% owner) — https://whiteintel.dev/entity/ec9ac26b-07ce-5595-b013-3e7386eb27ef
- **Sinha Vikas** (10% owner) — https://whiteintel.dev/entity/18e020b0-56a3-59b8-9153-f4b37182f5ad
- **Sinha Vikas** (10% owner) — https://whiteintel.dev/entity/18e020b0-56a3-59b8-9153-f4b37182f5ad
- **Sinha Vikas** (10% owner) — https://whiteintel.dev/entity/18e020b0-56a3-59b8-9153-f4b37182f5ad
- **SAMSARA OPPORTUNITY FUND, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/c12a03b8-0560-5cf1-836c-4ee78aba98da
- **Samsara BioCapital GP, LLC** (tenpercentowner) — https://whiteintel.dev/entity/f27fb560-ac80-5f57-aada-2abf63da4070
- **AKKARAJU SRINIVAS** (tenpercentowner) — https://whiteintel.dev/entity/ec9ac26b-07ce-5595-b013-3e7386eb27ef
- **Samsara BioCapital, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/288d366d-faca-54e6-a55f-2d1f307cc7f2
- **SAMSARA OPPORTUNITY FUND GP, LLC** (tenpercentowner) — https://whiteintel.dev/entity/67b9156b-9c80-5c75-a7ee-a9221afc5fab
- **Sinha Vikas** (tenpercentowner) — https://whiteintel.dev/entity/18e020b0-56a3-59b8-9153-f4b37182f5ad
- **JOVAN-EMBIRICOS MORANA** (tenpercentowner) — https://whiteintel.dev/entity/3abd3394-3e0a-59ae-a36a-e65da281cafc
- **HALLAL DAVID** (tenpercentowner) — https://whiteintel.dev/entity/059913f9-4227-580d-87df-32f7dcbd4f7e
- **GILEAD SCIENCES, INC.** (tenpercentowner) — https://whiteintel.dev/entity/601e55e5-ff7d-5603-a86e-1f1ee799a384
- **GLOBEWAYS HOLDINGS II LTD** (tenpercentowner) — https://whiteintel.dev/entity/a3336ff2-277c-5d26-9cde-922724e923da
- **F2 MG LTD** (tenpercentowner) — https://whiteintel.dev/entity/e9714786-8f2a-5ae1-938d-90c3752a458e
- **F2 BIOSCIENCE AV 2022 LLC** (tenpercentowner) — https://whiteintel.dev/entity/debad3a3-9481-5264-a27f-1892d3af5d48
- **ELEVATEBIO, LLC** (tenpercentowner) — https://whiteintel.dev/entity/5040c8d2-1c86-5f4f-b139-2f459141e730
- **F2 - TPO INVESTMENTS LLC** (tenpercentowner) — https://whiteintel.dev/entity/896ba119-6192-5d0f-99be-92deb63482ed
- **GADICKE ANSBERT** (tenpercentowner) — https://whiteintel.dev/entity/3d6fb5d6-4514-5ca9-bf31-0f4073abbd96
- **F2 CAPITAL I 2020** (tenpercentowner) — https://whiteintel.dev/entity/31a880b2-929a-5bd9-b1d0-3f059ee21099
- **GLOBEWAYS HOLDINGS LTD** (tenpercentowner) — https://whiteintel.dev/entity/740e888b-6f64-55f0-94de-ef680f6c1aa9
- **F2 MC, LLC** (tenpercentowner) — https://whiteintel.dev/entity/46cab0ae-f7af-52cf-9fa2-2c4d0fea668a
- **Redmile Group, LLC** (tenpercentowner) — https://whiteintel.dev/entity/4d5d139b-079d-5f97-a23d-55867544d098
- **Green Jeremy** (tenpercentowner) — https://whiteintel.dev/entity/9a44ab54-8a62-5436-912e-17661f2862a3

### UBO chain (walk to the ultimate owner)

A **158-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Kalaris Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d · Structured JSON: https://whiteintel.dev/api/public/dossier/de4c956a-976e-5209-89f2-2f72662ee99d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._